CHMP2B, also found to be upregulated, was associated with ALS and FTD, with the latter having, among its causes, a gain-of-function mutation in the CHMP2B gene (Ugbode and West, 2021; Chen et al., 2022). Here, CHMP2B is linked to frontotemporal dementia.